Lucid Diagnostics Inc.
LUCD
$1.14
-$0.01-0.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.71M | 4.40M | 4.36M | 4.17M | 4.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.71M | 4.40M | 4.36M | 4.17M | 4.35M |
| Cost of Revenue | 6.67M | 6.96M | 6.94M | 6.99M | 7.10M |
| Gross Profit | -1.97M | -2.56M | -2.58M | -2.82M | -2.75M |
| SG&A Expenses | 41.58M | 39.62M | 39.13M | 38.59M | 36.62M |
| Depreciation & Amortization | 301.00K | 302.00K | 302.00K | 302.00K | 471.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.35M | 52.40M | 52.30M | 51.92M | 50.40M |
| Operating Income | -49.64M | -48.01M | -47.94M | -47.75M | -46.05M |
| Income Before Tax | -58.01M | -53.29M | -55.26M | -61.83M | -45.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -58.01 | -53.29 | -55.26 | -61.83 | -45.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.01M | -53.29M | -55.26M | -61.83M | -45.53M |
| EBIT | -49.64M | -48.01M | -47.94M | -47.75M | -46.05M |
| EBITDA | -48.77M | -47.12M | -47.06M | -46.86M | -44.89M |
| EPS Basic | -0.82 | -0.90 | -1.05 | -1.20 | -1.07 |
| Normalized Basic EPS | -0.32 | -0.38 | -0.46 | -0.53 | -0.57 |
| EPS Diluted | -0.82 | -0.90 | -1.05 | -1.20 | -1.07 |
| Normalized Diluted EPS | -0.32 | -0.38 | -0.46 | -0.53 | -0.57 |
| Average Basic Shares Outstanding | 407.35M | 334.34M | 276.54M | 225.76M | 201.98M |
| Average Diluted Shares Outstanding | 407.35M | 334.34M | 276.54M | 225.76M | 201.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |